6726 - 6750 of 7916 Results
Title
Year
- Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function2015RESTRICTEDTitle: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and functionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 100End Page: 114Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008Citation Count: 23
- Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins2015OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Best OA location URL: https://europepmc.org/articles/pmc4458424?pdf=renderCitation Count: 37
-
RESTRICTEDTitle: Minimal change multiple system atrophy: An aggressive variant?Journal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 960End Page: 967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26220Citation Count: 48
-
OPENTitle: Onset of Mild Cognitive Impairment in Parkinson DiseaseJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 30Issue #: 2Start Page: 127End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000088Best OA location URL: https://epublications.marquette.edu/cgi/viewcontent.cgi?article=1530&context=nursing_facCitation Count: 28
- Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor2015OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: https://europepmc.org/articles/pmc4434483?pdf=renderCitation Count: 48
- Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials2015RESTRICTEDTitle: Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trialsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 14Start Page: 1488End Page: 1494Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001451Best OA location URL: https://europepmc.org/articles/pmc4395889?pdf=renderCitation Count: 49
-
OPENTitle: Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the BrainJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 4Issue #: 7Start Page: 788End Page: 795Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.5b00040Best OA location URL: https://europepmc.org/articles/pmc4547530?pdf=renderCitation Count: 27
- Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism2015OPENTitle: Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonismJournal Name: NeuroradiologyPublisher: Springer Science and Business Media LLCVol: 57Issue #: 7Start Page: 655End Page: 669Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00234-015-1515-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00234-015-1515-7.pdfCitation Count: 41
-
OPENTitle: Performance of the CogState computerized battery in the Mayo Clinic Study on AgingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 11Issue #: 11Start Page: 1367End Page: 1376Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2015.01.008Best OA location URL: https://europepmc.org/articles/pmc4595161?pdf=renderCitation Count: 103
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice2015OPENTitle: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 172End Page: 195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031Best OA location URL: https://europepmc.org/articles/pmc4526103?pdf=renderCitation Count: 216
-
RESTRICTEDTitle: Activation of the E3 ubiquitin ligase ParkinJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 43Issue #: 2Start Page: 269End Page: 274Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bst20140321Best OA location URL: https://europepmc.org/articles/pmc4859148?pdf=renderCitation Count: 45
- Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling Pathway2015OPENTitle: Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling PathwayJournal Name: Molecular and Cellular BiologyPublisher: Informa UK LimitedVol: 35Issue #: 11Start Page: 1992End Page: 2006Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1128/mcb.01510-14Best OA location URL: https://mcb.asm.org/content/mcb/35/11/1992.full.pdfCitation Count: 19
- The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study2015RESTRICTEDTitle: The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 4Start Page: 1736End Page: 1742Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.037Citation Count: 42
- Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease2015OPENTitle: Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00101Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00101/pdfCitation Count: 63
- α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation2015OPENTitle: α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1417883112Best OA location URL: https://www.pnas.org/content/pnas/112/15/E1926.full.pdfCitation Count: 136
- Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease2015OPENTitle: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 77Issue #: 6Start Page: 930End Page: 941Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24375Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24375Citation Count: 47
-
OPENTitle: ER proteostasis disturbances in Parkinson's disease: novel insightsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2015.00039Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2015.00039/pdfCitation Count: 31
- Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies2015OPENTitle: Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodiesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0010-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0010-2Citation Count: 132
-
OPENTitle: Genetic analysis of FMR1 repeat expansion in essential tremorJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 593Issue #:Start Page: 114End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.03.027Best OA location URL: https://europepmc.org/articles/pmc4393799?pdf=renderCitation Count: 13
-
OPENTitle: Stiripentol for the treatment of super-refractory status epilepticusJournal Name: Acta Neurologica ScandinavicaPublisher: Hindawi LimitedVol: 132Issue #: 6Start Page: 435End Page: 439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12403Best OA location URL: https://doi.org/10.1111/ane.12403Citation Count: 37
- A visual review of the interactome of LRRK2: Using deep‐curated molecular interaction data to represent biology2015RESTRICTEDTitle: A visual review of the interactome of LRRK2: Using deep‐curated molecular interaction data to represent biologyJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 8Start Page: 1390End Page: 1404Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/pmic.201400390Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.201400390Citation Count: 38
- Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene2015OPENTitle: Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 981End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26213Best OA location URL: https://europepmc.org/articles/pmc4478229?pdf=renderCitation Count: 56
- Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy2015OPENTitle: Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0008-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0008-9Citation Count: 136
-
OPENTitle: Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of AgingJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 14Start Page: 1433End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001437Best OA location URL: https://europepmc.org/articles/pmc4395890?pdf=renderCitation Count: 115
-
OPENTitle: Low‐variance RNAs identify Parkinson's disease molecular signature in bloodJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26205Best OA location URL: https://europepmc.org/articles/pmc4439364?pdf=renderCitation Count: 18